Document is current
Any future updates will be listed below
-
Authors
Cho, Hyun-Ju
Smith, Joy
Switzer, Christopher H
Louka, Eleni https://orcid.org/0000-0002-0543-7397
Charles, Rebecca L https://orcid.org/0000-0003-4115-6135
Prysyazhna, Oleksandra https://orcid.org/0000-0002-0394-7000
Schroder, Ewald
Fernandez-Caggiano, Mariana
de Jesus, Daniel Simoes https://orcid.org/0000-0002-0828-0305
Eminaga, Seda
Yin, Xiaoke https://orcid.org/0000-0002-5172-0935
Yang, Xiaoping
Lynham, Steven
Mayr, Manuel
Morales, Valle https://orcid.org/0000-0003-0856-5121
Bianchi, Katiuscia https://orcid.org/0000-0002-4549-4476
Rajeeve, Vinothini https://orcid.org/0000-0002-6361-4291
Cutillas, Pedro R https://orcid.org/0000-0002-3426-2274
Mead, Adam J
Eaton, Philip https://orcid.org/0000-0003-0748-2367
-
Funding
Funding for this research was provided by:
British Heart Foundation
Barts Charity (Cardiovascular Programme Award G00913)
Barts Charity (MGU0401)
Barts Charity (C16420/A18066)
UKRI | Medical Research Council (MR/R01065X/2)
NIHR | National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley
Cancer Research UK
UK Research and Innovation (EP/Y027698/1)
- License Information
-
More Information
Article History
Received: 4 April 2023
Revised: 19 June 2025
Accepted: 24 June 2025
First Online: 10 July 2025
Disclosure and competing interests statement
: The authors declare no competing interests. PE acknowledges he was an unpaid advisor to Theracryf plc.
